Advertisement
Screener

LEXICON PHARMACEUTICALS, INC. (LXRX) Licenses Revenue (Deprecated 2018-01-31)

2.8 / 5 stars · 68/120 Roast Me

LEXICON PHARMACEUTICALS, INC. Licenses Revenue (Deprecated 2018-01-31)

LEXICON PHARMACEUTICALS, INC. (LXRX) reported Licenses Revenue (Deprecated 2018-01-31) of $82.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-03.

Discontinued › Income Statement › Other Income

us-gaap:LicensesRevenue · last filed 2018-05-03

  • LEXICON PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $82.00K, a 1071.43% increase year-over-year.
  • LEXICON PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $114.00K, a 216.67% increase year-over-year.
  • LEXICON PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
  • LEXICON PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $57.00K, a 35.23% decline year-over-year.
  • LEXICON PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for fiscal 2017 was $178.00K, a 14.84% increase from fiscal 2016.
  • LEXICON PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for fiscal 2016 was $155.00K, a 45.80% decline from fiscal 2015.
  • LEXICON PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for fiscal 2015 was $286.00K, a 9.58% increase from fiscal 2014.
  • LEXICON PHARMACEUTICALS, INC. licenses revenue (deprecated 2018-01-31) for fiscal 2014 was $261.00K, a 130.97% increase from fiscal 2013.
Period endLicenses Revenue (Deprecated 2018-01-31) 3 monthLicenses Revenue (Deprecated 2018-01-31) 6 monthLicenses Revenue (Deprecated 2018-01-31) 9 monthLicenses Revenue (Deprecated 2018-01-31) 12 month
2018-03-31$82.00K
10-Q · filed 2018-05-03
$196.00K
derived: sum of 2 quarters · filed 2018-05-03
$196.00K
derived: sum of 3 quarters · filed 2018-05-03
$253.00K
derived: sum of 4 quarters · filed 2018-05-03
2017-12-31$114.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$114.00K
derived: sum of 2 quarters · filed 2018-03-01
$171.00K
derived: sum of 3 quarters · filed 2018-03-01
$178.00K
10-K · filed 2018-03-01
2017-09-30$0.00
10-Q · filed 2017-11-08
$57.00K
derived: sum of 2 quarters · filed 2017-11-08
$64.00K
10-Q · filed 2017-11-08
$100.00K
derived: sum of 4 quarters · filed 2018-05-03
2017-06-30$57.00K
10-Q · filed 2017-08-01
$64.00K
10-Q · filed 2017-08-01
$100.00K
derived: sum of 3 quarters · filed 2018-05-03
$131.00K
derived: sum of 4 quarters · filed 2018-05-03
2017-03-31$7.00K
10-Q · filed 2018-05-03
$43.00K
derived: sum of 2 quarters · filed 2018-05-03
$74.00K
derived: sum of 3 quarters · filed 2018-05-03
$162.00K
derived: sum of 4 quarters · filed 2018-05-03
2016-12-31$36.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$67.00K
derived: sum of 2 quarters · filed 2018-03-01
$155.00K
derived: sum of 3 quarters · filed 2018-03-01
$155.00K
10-K · filed 2018-03-01
2016-09-30$31.00K
10-Q · filed 2017-11-08
$119.00K
derived: sum of 2 quarters · filed 2017-11-08
$119.00K
10-Q · filed 2017-11-08
$306.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30$88.00K
10-Q · filed 2017-08-01
$88.00K
10-Q · filed 2017-08-01
$275.00K
derived: sum of 3 quarters · filed 2018-03-01
$336.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31$0.00
10-Q · filed 2017-05-04
$187.00K
derived: sum of 2 quarters · filed 2018-03-01
$248.00K
derived: sum of 3 quarters · filed 2018-03-01
$286.00K
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$187.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$248.00K
derived: sum of 2 quarters · filed 2018-03-01
$286.00K
derived: sum of 3 quarters · filed 2018-03-01
$286.00K
10-K · filed 2018-03-01
2015-09-30$61.00K
10-Q · filed 2016-11-07
$99.00K
derived: sum of 2 quarters · filed 2016-11-07
$99.00K
10-Q · filed 2016-11-07
$99.00K
derived: sum of 4 quarters · filed 2017-03-06
2015-06-30$38.00K
10-Q · filed 2016-08-04
$38.00K
10-Q · filed 2016-08-04
$38.00K
derived: sum of 3 quarters · filed 2017-03-06
$145.00K
derived: sum of 4 quarters · filed 2017-03-06
2015-03-31$0.00
10-Q · filed 2015-05-05
$0.00
derived: sum of 2 quarters · filed 2017-03-06
$107.00K
derived: sum of 3 quarters · filed 2017-03-06
$156.00K
derived: sum of 4 quarters · filed 2017-03-06
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06
$107.00K
derived: sum of 2 quarters · filed 2017-03-06
$156.00K
derived: sum of 3 quarters · filed 2017-03-06
$261.00K
10-K · filed 2017-03-06
2014-09-30$107.00K
10-Q · filed 2015-11-09
$156.00K
derived: sum of 2 quarters · filed 2015-11-09
$261.00K
10-Q · filed 2015-11-09
$295.00K
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30$49.00K
10-Q · filed 2015-08-07
$154.00K
10-Q · filed 2015-08-07
$188.00K
derived: sum of 3 quarters · filed 2016-03-11
$188.00K
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31$105.00K
10-Q · filed 2015-05-05
$139.00K
derived: sum of 2 quarters · filed 2016-03-11
$139.00K
derived: sum of 3 quarters · filed 2016-03-11
$142.00K
derived: sum of 4 quarters · filed 2016-03-11
2013-12-31$34.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
$34.00K
derived: sum of 2 quarters · filed 2016-03-11
$37.00K
derived: sum of 3 quarters · filed 2016-03-11
$113.00K
10-K · filed 2016-03-11
2013-09-30$0.00
10-Q · filed 2014-11-06
$3.00K
derived: sum of 2 quarters · filed 2014-11-06
$79.00K
10-Q · filed 2014-11-06
$79.00K
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30$3.00K
10-Q · filed 2014-08-07
$79.00K
10-Q · filed 2014-08-07
$79.00K
derived: sum of 3 quarters · filed 2015-03-12
$237.00K
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31$76.00K
10-Q · filed 2014-05-08
$76.00K
derived: sum of 2 quarters · filed 2015-03-12
$234.00K
derived: sum of 3 quarters · filed 2015-03-12
$234.00K
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$158.00K
derived: sum of 2 quarters · filed 2015-03-12
$158.00K
derived: sum of 3 quarters · filed 2015-03-12
$306.00K
10-K · filed 2015-03-12
2012-09-30$158.00K
10-Q · filed 2013-11-12
$158.00K
derived: sum of 2 quarters · filed 2013-11-12
$306.00K
10-Q · filed 2013-11-12
$329.00K
derived: sum of 4 quarters · filed 2014-03-07
2012-06-30$0.00
10-Q · filed 2013-08-01
$148.00K
10-Q · filed 2013-08-01
$171.00K
derived: sum of 3 quarters · filed 2014-03-07
$191.00K
derived: sum of 4 quarters · filed 2014-03-07
2012-03-31$148.00K
10-Q · filed 2013-05-10
$171.00K
derived: sum of 2 quarters · filed 2014-03-07
$191.00K
derived: sum of 3 quarters · filed 2014-03-07
$285.00K
derived: sum of 4 quarters · filed 2014-03-07
2011-12-31$23.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07
$43.00K
derived: sum of 2 quarters · filed 2014-03-07
$137.00K
derived: sum of 3 quarters · filed 2014-03-07
$217.00K
10-K · filed 2014-03-07
2011-09-30$20.00K
10-Q · filed 2012-11-07
$114.00K
derived: sum of 2 quarters · filed 2012-11-07
$194.00K
10-Q · filed 2012-11-07
$693.00K
derived: sum of 4 quarters · filed 2013-03-11
2011-06-30$94.00K
10-Q · filed 2012-08-02
$174.00K
10-Q · filed 2012-08-02
$673.00K
derived: sum of 3 quarters · filed 2013-03-11
$822.00K
derived: sum of 4 quarters · filed 2013-03-11
2011-03-31$80.00K
10-Q · filed 2012-05-03
$579.00K
derived: sum of 2 quarters · filed 2013-03-11
$728.00K
derived: sum of 3 quarters · filed 2013-03-11
$797.00K
derived: sum of 4 quarters · filed 2013-03-11
2010-12-31$499.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11
$648.00K
derived: sum of 2 quarters · filed 2013-03-11
$717.00K
derived: sum of 3 quarters · filed 2013-03-11
$717.00K
10-K · filed 2013-03-11
2010-09-30$149.00K
10-Q · filed 2011-11-01
$218.00K
derived: sum of 2 quarters · filed 2011-11-01
$218.00K
10-Q · filed 2011-11-01
2010-06-30$69.00K
10-Q · filed 2011-08-09
$69.00K
10-Q · filed 2011-08-09
2009-12-31$1.37M
10-K · filed 2012-03-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
GERON CORP (GERN)United States$0.803B-12.14
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78